• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

内皮抑素和血管内皮生长因子抗体可能有助于肺动脉高压的分类。

Endostatin and Vascular Endothelial Growth Factor-Ab May Contribute to Classification of Pulmonary Hypertension.

作者信息

Adachi Shiro, Kikuchi Ryosuke, Shimokata Shigetake, Suzuki Atsuo, Yoshida Masahiro, Imai Ryo, Nakano Yoshihisa, Kondo Takahisa, Murohara Toyoaki

机构信息

Department of Cardiology, Nagoya University Hospital Nagoya Japan.

Department of Medical Technique, Nagoya University Hospital Nagoya Japan.

出版信息

Circ Rep. 2021 Feb 19;3(3):161-169. doi: 10.1253/circrep.CR-20-0096.

DOI:10.1253/circrep.CR-20-0096
PMID:33738349
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7956881/
Abstract

Pulmonary hypertension (PH) is characterized by dysregulation of small pulmonary arteries. In addition to endostatin (ES), placenta growth factor (PlGF), vascular endothelial growth factor-A (VEGF-A), and the anti-angiogenesis isoform of VEGF-A (VEGF-Ab) are associated with PH. However, the usefulness of these biomarkers in PH in unknown. We investigated whether these 4 biomarkers are related to PH classification. Between July 2015 and August 2017, 33 control patients and 107 PH patients were enrolled in the study. Among the PH patients, 48 had pulmonary arterial hypertension (PAH), 5 had left heart disease-associated PH (LHD-PH), 4 had lung disease-associated PH (LD-PH), and 50 had chronic thromboembolic PH (CTEPH). Among the PAH patients, 16 had idiopathic PAH (IPAH) and 17 had connective tissue disease-associated PAH (CTD-PAH). PlGF, total VEGF-A, and VEGF-Ab levels were measured in the control and PH groups. ES was only measured in the PH group. VEGF-Ab levels were significantly higher in the LD-PH group than in the PAH, LHD-PH, and CTEPH groups (all P<0.001). PlGF levels were significantly higher in the CTD-PAH group than in the IPAH and control groups. ES levels were significantly correlated with the 6-min walk distance (P<0.001), B-type natriuretic peptide (P<0.001), and pulmonary vascular resistance (P=0.008). ES could detect CTD-PAH in PAH and may be an indicator of PH severity. VEGF-Ab was useful in detecting LD-PH.

摘要

肺动脉高压(PH)的特征是小肺动脉调节异常。除内皮抑素(ES)外,胎盘生长因子(PlGF)、血管内皮生长因子-A(VEGF-A)以及VEGF-A的抗血管生成异构体(VEGF-Ab)也与PH相关。然而,这些生物标志物在PH中的作用尚不清楚。我们研究了这4种生物标志物是否与PH分类有关。2015年7月至2017年8月,33例对照患者和107例PH患者纳入本研究。在PH患者中,48例患有肺动脉高压(PAH),5例患有左心疾病相关性PH(LHD-PH),4例患有肺部疾病相关性PH(LD-PH),50例患有慢性血栓栓塞性PH(CTEPH)。在PAH患者中,16例患有特发性PAH(IPAH),17例患有结缔组织病相关性PAH(CTD-PAH)。在对照组和PH组中测量了PlGF、总VEGF-A和VEGF-Ab水平。ES仅在PH组中测量。LD-PH组的VEGF-Ab水平显著高于PAH、LHD-PH和CTEPH组(均P<0.001)。CTD-PAH组的PlGF水平显著高于IPAH组和对照组。ES水平与6分钟步行距离(P<0.001)、B型利钠肽(P<0.001)和肺血管阻力(P=0.008)显著相关。ES可在PAH中检测出CTD-PAH,可能是PH严重程度的一个指标。VEGF-Ab有助于检测LD-PH。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9573/7956881/d7bd575d3123/circrep-3-161-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9573/7956881/2f5478aa6e74/circrep-3-161-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9573/7956881/ff7460a97836/circrep-3-161-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9573/7956881/98f6d3736094/circrep-3-161-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9573/7956881/8e68d9d75fe6/circrep-3-161-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9573/7956881/d7bd575d3123/circrep-3-161-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9573/7956881/2f5478aa6e74/circrep-3-161-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9573/7956881/ff7460a97836/circrep-3-161-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9573/7956881/98f6d3736094/circrep-3-161-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9573/7956881/8e68d9d75fe6/circrep-3-161-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9573/7956881/d7bd575d3123/circrep-3-161-g005.jpg

相似文献

1
Endostatin and Vascular Endothelial Growth Factor-Ab May Contribute to Classification of Pulmonary Hypertension.内皮抑素和血管内皮生长因子抗体可能有助于肺动脉高压的分类。
Circ Rep. 2021 Feb 19;3(3):161-169. doi: 10.1253/circrep.CR-20-0096.
2
Angiogenic and inflammatory biomarkers in the differentiation of pulmonary hypertension.血管生成和炎症生物标志物在肺动脉高压鉴别诊断中的作用
Scand Cardiovasc J. 2017 Oct;51(5):261-270. doi: 10.1080/14017431.2017.1359419. Epub 2017 Aug 4.
3
Regulation of human feto-placental endothelial barrier integrity by vascular endothelial growth factors: competitive interplay between VEGF-Aa, VEGF-Ab, PIGF and VE-cadherin.血管内皮生长因子对人胎儿-胎盘内皮屏障完整性的调节:VEGF-Aa、VEGF-Ab、胎盘生长因子与血管内皮钙黏蛋白之间的竞争性相互作用
Clin Sci (Lond). 2017 Nov 23;131(23):2763-2775. doi: 10.1042/CS20171252. Print 2017 Dec 1.
4
New potential diagnostic biomarkers for pulmonary hypertension.肺动脉高压的新潜在诊断生物标志物。
Eur Respir J. 2015 Nov;46(5):1390-6. doi: 10.1183/13993003.00187-2015. Epub 2015 Aug 6.
5
Association between levels of anti-angiogenic isoform of vascular endothelial growth factor A and pulmonary hypertension.血管内皮生长因子A的抗血管生成异构体水平与肺动脉高压之间的关联。
Int J Cardiol. 2016 Nov 1;222:416-420. doi: 10.1016/j.ijcard.2016.07.277. Epub 2016 Aug 1.
6
Angiogenic and inflammatory biomarkers for screening and follow-up in patients with pulmonary arterial hypertension.用于肺动脉高压患者筛查和随访的血管生成和炎症生物标志物。
Scand J Rheumatol. 2018 Jul;47(4):319-324. doi: 10.1080/03009742.2017.1378714. Epub 2018 Mar 12.
7
Antiangiogenic actions of vascular endothelial growth factor-A165b, an inhibitory isoform of vascular endothelial growth factor-A, in human obesity.血管内皮生长因子-A的抑制性异构体血管内皮生长因子-A165b在人类肥胖中的抗血管生成作用。
Circulation. 2014 Sep 23;130(13):1072-80. doi: 10.1161/CIRCULATIONAHA.113.008171. Epub 2014 Aug 12.
8
CTLA-4 Expression Is a Promising Biomarker of Idiopathic Pulmonary Arterial Hypertension and Allows Differentiation of the Type of Pulmonary Hypertension.CTLA-4 表达是特发性肺动脉高压有前途的生物标志物,并可区分肺动脉高压的类型。
Int J Mol Sci. 2022 Dec 14;23(24):15910. doi: 10.3390/ijms232415910.
9
Pulmonary capillary endothelial metabolic dysfunction: severity in pulmonary arterial hypertension related to connective tissue disease versus idiopathic pulmonary arterial hypertension.肺毛细血管内皮代谢功能障碍:与结缔组织病相关的肺动脉高压与特发性肺动脉高压的严重程度比较
Arthritis Rheum. 2008 Apr;58(4):1156-64. doi: 10.1002/art.23405.
10
Urinary and circulating levels of the anti-angiogenic isoform of vascular endothelial growth factor-A in patients with chronic kidney disease.慢性肾脏病患者血管内皮生长因子-A 的抗血管生成同工型在尿中和循环中的水平。
Clin Chim Acta. 2017 Dec;475:102-108. doi: 10.1016/j.cca.2017.10.014. Epub 2017 Oct 18.

引用本文的文献

1
Investigating the Role of Gene Polymorphisms in Hypertension: Evidence from the Jordanian Population.探究基因多态性在高血压中的作用:来自约旦人群的证据。
Vasc Health Risk Manag. 2025 Sep 3;21:705-717. doi: 10.2147/VHRM.S536434. eCollection 2025.
2
Molecular Pathogenesis of Connective Tissue Disease-Associated Pulmonary Arterial Hypertension: A Narrative Review.结缔组织病相关肺动脉高压的分子发病机制:一项叙述性综述
Biomolecules. 2025 May 27;15(6):772. doi: 10.3390/biom15060772.
3
Prevalence, molecular mechanisms and diagnostic approaches to pulmonary arterial hypertension in connective tissue diseases.

本文引用的文献

1
Correlation of Right Ventricular Wall Stress With Plasma B-Type Natriuretic Peptide Levels in Patients With Pulmonary Hypertension.肺动脉高压患者右心室壁应力与血浆 B 型利钠肽水平的相关性。
Circ J. 2019 May 24;83(6):1278-1285. doi: 10.1253/circj.CJ-18-1155. Epub 2019 Apr 9.
2
Prevalence of primary Sjögren's syndrome in patients undergoing evaluation for pulmonary arterial hypertension.原发性干燥综合征在肺动脉高压患者评估中的患病率。
PLoS One. 2018 May 15;13(5):e0197297. doi: 10.1371/journal.pone.0197297. eCollection 2018.
3
Differential Expression of VEGF-A Isoforms Is Critical for Development of Pulmonary Fibrosis.
结缔组织病相关肺动脉高压的患病率、分子机制及诊断方法
Rheumatol Int. 2025 Apr 4;45(4):87. doi: 10.1007/s00296-025-05845-z.
4
Recent developments in connective tissue disease associated pulmonary arterial hypertension.结缔组织病相关肺动脉高压的最新进展
Int J Cardiol Congenit Heart Dis. 2024 Apr 14;16:100513. doi: 10.1016/j.ijcchd.2024.100513. eCollection 2024 Jun.
5
Correlation between vascular endothelial growth factor, soluble urokinase plasminogen activator receptor, and tricuspid annular plane systolic excursion/systolic pulmonary artery pressure ratio in group E chronic obstructive lung disease.E 组慢性阻塞性肺疾病患者中血管内皮生长因子、可溶性尿激酶型纤溶酶原激活物受体与三尖瓣环平面收缩期位移/收缩期肺动脉压比值的相关性。
Rev Assoc Med Bras (1992). 2024 Nov 11;70(10):e20240589. doi: 10.1590/1806-9282.20240589. eCollection 2024.
6
Diagnostic values of serum BNP, PTX3, and VEGF in acute pulmonary embolism complicated by pulmonary artery hypertension and their correlations with severity of pulmonary artery hypertension.血清 BNP、PTX3 和 VEGF 在急性肺栓塞合并肺动脉高压中的诊断价值及其与肺动脉高压严重程度的相关性。
Immun Inflamm Dis. 2023 Sep;11(9):e986. doi: 10.1002/iid3.986.
7
Serum Biomarkers in Connective Tissue Disease-Associated Pulmonary Arterial Hypertension.结缔组织病相关肺动脉高压的血清生物标志物。
Int J Mol Sci. 2023 Feb 20;24(4):4178. doi: 10.3390/ijms24044178.
VEGF-A 亚型的差异表达对肺纤维化的发展至关重要。
Am J Respir Crit Care Med. 2017 Aug 15;196(4):479-493. doi: 10.1164/rccm.201603-0568OC.
4
Association between levels of anti-angiogenic isoform of vascular endothelial growth factor A and pulmonary hypertension.血管内皮生长因子A的抗血管生成异构体水平与肺动脉高压之间的关联。
Int J Cardiol. 2016 Nov 1;222:416-420. doi: 10.1016/j.ijcard.2016.07.277. Epub 2016 Aug 1.
5
Inhibition of angiogenesis by platelets in systemic sclerosis patients.血小板对系统性硬化症患者血管生成的抑制作用。
Arthritis Res Ther. 2015 Nov 19;17:332. doi: 10.1186/s13075-015-0848-2.
6
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT).2015年欧洲心脏病学会(ESC)/欧洲呼吸学会(ERS)肺动脉高压诊断和治疗指南:欧洲心脏病学会(ESC)和欧洲呼吸学会(ERS)肺动脉高压诊断和治疗联合工作组:得到以下组织认可:欧洲儿科和先天性心脏病协会(AEPC)、国际心肺移植学会(ISHLT)。
Eur Heart J. 2016 Jan 1;37(1):67-119. doi: 10.1093/eurheartj/ehv317. Epub 2015 Aug 29.
7
New potential diagnostic biomarkers for pulmonary hypertension.肺动脉高压的新潜在诊断生物标志物。
Eur Respir J. 2015 Nov;46(5):1390-6. doi: 10.1183/13993003.00187-2015. Epub 2015 Aug 6.
8
Biomarkers of pulmonary hypertension in patients with scleroderma: a case-control study.硬皮病患者肺动脉高压的生物标志物:一项病例对照研究。
Arthritis Res Ther. 2015 Aug 6;17(1):201. doi: 10.1186/s13075-015-0712-4.
9
Vascular endothelial growth factor receptor 3 signaling contributes to angioobliterative pulmonary hypertension.血管内皮生长因子受体 3 信号通路促进血管闭塞性肺动脉高压。
Pulm Circ. 2015 Mar;5(1):101-16. doi: 10.1086/679704.
10
Serum endostatin is a genetically determined predictor of survival in pulmonary arterial hypertension.血清内皮抑素是肺动脉高压患者生存的基因决定预测指标。
Am J Respir Crit Care Med. 2015 Jan 15;191(2):208-18. doi: 10.1164/rccm.201409-1742OC.